These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4805105)

  • 1. New look at monoamine oxidase inhibitors. The new biochemical background.
    Sandler M
    Proc R Soc Med; 1973 Sep; 66(9):946-7. PubMed ID: 4805105
    [No Abstract]   [Full Text] [Related]  

  • 2. Human brain monoamine oxidase: multiple forms and selective inhibitors.
    Youdim MB; Collins GG; Sandler M; Bevan Jones AB; Pare CM; Nicholson WJ
    Nature; 1972 Mar; 236(5344):225-8. PubMed ID: 4553640
    [No Abstract]   [Full Text] [Related]  

  • 3. [Moclobemide].
    Gleiter C; Volz HP
    Dtsch Med Wochenschr; 1995 Aug; 120(34-35):1175-6. PubMed ID: 7656852
    [No Abstract]   [Full Text] [Related]  

  • 4. Monoamine oxidases: the present status.
    Sandler M; Youdim MB
    Int Pharmacopsychiatry; 1974; 9(1):27-34. PubMed ID: 4599324
    [No Abstract]   [Full Text] [Related]  

  • 5. On the dual nature of monoamine oxidase.
    Knoll J
    Horiz Biochem Biophys; 1978; 5():37-64. PubMed ID: 355087
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Monoamine oxidase activity in distinct populations of rat brain mitochondria.
    Bourne R; Lai JC; Owen F; Crow TJ
    Br J Pharmacol; 1975 Oct; 55(2):298P. PubMed ID: 1201425
    [No Abstract]   [Full Text] [Related]  

  • 7. Some parameters affecting the activity of monoamine oxidase in purified bovine brain mitochondria.
    Gabay S; Achee FM; Mentes G
    J Neurochem; 1976 Aug; 27(2):415-24. PubMed ID: 9476
    [No Abstract]   [Full Text] [Related]  

  • 8. [Monoamine oxidase as a target for drug action].
    Drozak J; Kozłowski M
    Postepy Hig Med Dosw (Online); 2006; 60():498-515. PubMed ID: 17060892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monoamine oxidase. 12. Substrate specificity of monoamine oxidase in the rabbit brain and liver].
    Nabatame E
    Nihon Yakurigaku Zasshi; 1971 Jul; 67(4):374-86. PubMed ID: 5165262
    [No Abstract]   [Full Text] [Related]  

  • 10. The monoamine oxidase type B inhibitor rasagiline in the treatment of Parkinson disease: is tyramine a challenge?
    Chen JJ; Wilkinson JR
    J Clin Pharmacol; 2012 May; 52(5):620-8. PubMed ID: 21628600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Properties of intestinal monoamine oxidase in the rat].
    Verevkina IV; Asnina VV; Gorkin VZ
    Vopr Med Khim; 1982; 28(2):88-93. PubMed ID: 7080482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of pig liver and pig brain mitochondrial monoamine oxidase.
    Ekstedt B; Oreland L
    Arch Int Pharmacodyn Ther; 1976 Jul; 222(1):157-65. PubMed ID: 984965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat.
    Egashira T; Ekstedt B; Kinemuchi H; Wiberg A; Oreland L
    Med Biol; 1976 Aug; 54(4):272-7. PubMed ID: 957813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine oxidase inhibitors for depression.
    Med Lett Drugs Ther; 1980 Jul; 22(14):58-60. PubMed ID: 7382910
    [No Abstract]   [Full Text] [Related]  

  • 15. Migraine.
    Hanington E
    Trans Med Soc Lond; 1971; 87():32-9. PubMed ID: 4949363
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinetic studies on rat brain monoamine oxidase.
    Huszti Z
    Mol Pharmacol; 1972 Jul; 8(4):385-97. PubMed ID: 5053580
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on monoamine oxidase of rat heart mitochondria. I. Purification and properties of the enzyme.
    Sen R; Parmar SS; Guha SR
    Acta Biol Med Ger; 1968; 21(1):1-11. PubMed ID: 5724353
    [No Abstract]   [Full Text] [Related]  

  • 18. Procaine HCl (Gerovital H3): a weak, reversible, fully competitive inhibitor of monoamine oxidase.
    MacFarlane MD
    Fed Proc; 1975 Jan; 34(1):108-10. PubMed ID: 1109354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB; Weinstock M
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference in actions of harmine on the oxidations of serotonin and tyramine by beef brain mitochondrial MAO.
    Yasuhara H; Sho S; Kamijo K
    Jpn J Pharmacol; 1972 Jun; 22(3):439-41. PubMed ID: 4539405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.